The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Transcriptional control of human p53-regulated genes
Abstract
The p53 protein regulates the transcription of many different genes in response to a wide variety of stress signals. Following DNA damage, p53 regulates key processes, including DNA repair, cell-cycle arrest, senescence and apoptosis, in order to suppress cancer. This Analysis article provides an overview of the current knowledge of p53-regulated genes in these pathways and others, and the mechanisms of their regulation. In addition, we present the most comprehensive list so far of human p53-regulated genes and their experimentally validated, functional binding sites that confer p53 regulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The tumor suppressor p53 functions primarily as a transcription factor.”
From Census and evaluation of p53 target genes (2017) · cites this paper as [5]
In the citing paper
“The prevailing function of the p53 tumor suppressor is the transcriptional control of target genes that regulate numerous cellular processes, including cell cycle and apoptosis.5, 6”
From Census and evaluation of p53 target genes (2017) · cites this paper as [5]
In the citing paper
“p53 is an crucial tumor suppressor that is mutated in more than 50% of human cancers”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Riley et al., 2008
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Self-citationVogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“These include several types of DNA damage: telomere shortening, hypoxia, mitotic spindle damage, heat or cold shock, unfolded proteins, improper ribosomal biogenesis, nutritional deprivation in a transformed cell, and even the activation of some oncogenes by mutatio”
BackgroundSelf-citationEddy, S. R. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.9.755 · Cited by 5,515
Sequence logos: a new way to display consensus sequences
Schneider, T. D., & Stephens, R. M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.20.6097 · Cited by 3,354
Durbin, R. M., Eddy, S. R., Krogh, A., & Mitchison, G. (1998) · Cambridge University Press eBooks · doi:10.1017/cbo9780511790492 · Cited by 3,255
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · cited 1×
“On the basis of X-ray crystallography studies of the p53 DNA-binding core domain bound to a p53-RE DNA sequence, the most important bases for interactions with the p53 protein are the central RCWWGY, which come into close contact with the amino acids from the p53 core domai”
BackgroundHistone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,234
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals
Yeo, G. W.-M., & Burge, C. B. (2004) · Journal of Computational Biology · doi:10.1089/1066527041410418 · Cited by 2,042
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Drosophila p53 controls Notch expression and balances apoptosis and proliferation
Simón, R., Aparicio, R., Housden, B. E., Bray, S. J., & Busturia, A. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1000-5 · Cited by 29
Negative regulation of p53 by Ras superfamily protein RBEL1A
Lui, K., An, J., Montalbano, J., Shi, J., Corcoran, C. A., He, Q., Sun, H., Sheikh, M. S., & Huang, Y. (2013) · Journal of Cell Science · doi:10.1242/jcs.118117 · Cited by 27
Liao, C., Xie, G., Zhu, L., Chen, X., Li, X., Lu, H., Xu, B., Ramot, Y., Paus, R., & Yue, Z. (2015) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.12.021 · Cited by 27
Self-aggregation and coaggregation of the p53 core fragment with its aggregation gatekeeper variant
Lei, J., Qi, R., Wei, G., Nussinov, R., & Ma, B. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp06538k · Cited by 27
Warren, T. A., Broit, N., Simmons, J. L., Pierce, C. J., Chawla, S., Lambie, D., Quagliotto, G., Brown, I., Parsons, P. G., Panizza, B. J., et al. (2016) · Scientific Reports · doi:10.1038/srep34081 · Cited by 27
Banerjee, S., & Chaturvedi, C. M. (2017) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2017.09.023 · Cited by 27
Selvam, M. K. P., Samanta, L., & Agarwal, A. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093155 · Cited by 27
Transgelin induces apoptosis of human prostate LNCaP cells through its interaction with p53
Zhang, Z.-W., Yang, Z., Zheng, Y., & Chen, Z.-D. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2009.76 · Cited by 26
Autophagy induction by low-dose cisplatin: The role of p53 in autophagy
Cho, K.-H., Park, J., Kwon, K., Lee, Y., So, H., Lee, K.-K., Lee, S.-Y., Moon, S., & Yang, S. (2013) · Oncology Reports · doi:10.3892/or.2013.2809 · Cited by 28
Dong, H. F., Shi, Q., Song, X., Fu, J., Hu, L., Xu, D., Su, C., Xia, X., Song, E., & Song, Y. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.017 · Cited by 26
Biderman, L., Poyurovsky, M. V., Assia, Y., Manley, J. L., & Prives, C. L. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06150-11 · Cited by 27
Alves, V. L. F., de Oliveira, M. B., Zanatta, D. B., Strauss, B. E., & Colleoni, G. W. B. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.03.011 · Cited by 25
Regenerative repair of Pifithrin-α in cerebral ischemia via VEGF dependent manner
Zhang, P., Lei, X., Sun, Y., Zhang, H., Chang, L., Li, C., Liu, D., Bhatta, N., Zhang, Z., & Jiang, C. (2016) · Scientific Reports · doi:10.1038/srep26295 · Cited by 26
Wang, X., Yan, M., Zhao, L., Wu, Q., Wu, C., Chang, X., & Zhou, Z. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122058 · Cited by 27
Etoposide-induced DNA damage affects multiple cellular pathways in addition to DNA damage response
Wei, F., Peng, H., Zhang, X., Hu, H., Jiang, D., Yin, A., Wen, L., Zheng, L., He, J., Mei, W., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24517 · Cited by 25
Multifunctional Compounds for Activation of the p53‐Y220C Mutant in Cancer
Miller, J. J., Orvain, C., Jozi, S., Clarke, R. M., Smith, J. R., Blanchet, A., Gaiddon, C., Warren, J. J., & Storr, T. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201802677 · Cited by 26
Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer
Idogawa, M., Nakase, H., Sasaki, Y., & Tokino, T. (2019) · Journal of Oncology · doi:10.1155/2019/4368068 · Cited by 27
NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity
Haider, N., Dutt, P., van de Kooij, B., Ho, J., Palomero, L., Pujana, M. Á., Yaffe, M. B., & Stambolic, V. (2020) · Oncogene · doi:10.1038/s41388-020-1361-x · Cited by 26
The guardian's choice: how p53 enables context‐specific decision‐making in individual cells
Friedel, L., & Loewer, A. (2021) · FEBS Journal · doi:10.1111/febs.15767 · Cited by 27
Higgins, C. E., Tang, J., Higgins, S. P., Gifford, C. C., Mian, B. M., Jones, D., Zhang, W., Costello, A., Conti, D. J., Samarakoon, R., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.678524 · Cited by 25
Alternative polyadenylation determines the functional landscape of inverted Alu repeats
Ku, J., Lee, K., Ku, D., Kim, S., Lee, J., Bang, H., Kim, N., Do, H., Lee, H., Lim, C., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.01.008 · Cited by 23
Kokolakis, G., Giannikaki, E. S., Stathopoulos, E., Avramidis, G., Tosca, A. D., & Krüger‐Krasagakis, S. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10689.x · Cited by 27
Ciribilli, Y., Andreotti, V., Menéndez, D., Langen, J.-S., Schönfelder, G., Resnick, M. A., & Inga, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010236 · Cited by 26
Biosemiotic Entropy of the Genome: Mutations and Epigenetic Imbalances Resulting in Cancer
Gryder, B. E., Nelson, C. W., & Shepard, S. S. (2013) · Entropy · doi:10.3390/e15010234 · Cited by 27
Molecular imaging of p53 signal pathway in lung cancer cell cycle arrest induced by cisplatin
Wang, S., Li, W., Xue, Z., Lu, Y., Narsinh, K. H., Fan, W., Li, X., Bu, Q., Wang, F., Liang, J., et al. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21930 · Cited by 26
Adikesavan, A. K., Karmakar, S., Pardo, P. S., Wang, L., Liu, S., Li, W., & Smith, C. S. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01216-13 · Cited by 26
Anaganti, S., Fernandez‐Cuesta, L., Langerød, A., Hainaut, P. L., & Olivier, M. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.10.008 · Cited by 26
Alterations in Mitochondrial and Endoplasmic Reticulum Signaling by p53 Mutants
Giorgi, C., Bonora, M., Missiroli, S., Morganti, C., Morciano, G., Wieckowski, M. R., & Pinton, P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00042 · Cited by 26
Yano, S., Wu, S., Sakao, K., & Hou, D. (2018) · BioFactors · doi:10.1002/biof.1431 · Cited by 26
Yan, Q., Ding, J., Khan, S. J., Lawton, L. N., & Shipp, M. A. (2023) · iScience · doi:10.1016/j.isci.2023.106444 · Cited by 25
Tumor Suppressor RASSF1A Promoter: p53 Binding and Methylation
Tian, Y., Hou, Y., Zhou, X., Cheng, H., & Zhou, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017017 · Cited by 25
Zhang, X., Machado, A. C. D., Ding, Y. C., Chen, Y., Lü, Y., Duan, Y., Tham, K. W., Chen, L., Rohs, R., & Qin, P. Z. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1219 · Cited by 25
Discovery of novel polycyclic spiro-fused carbocyclicoxindole-based anticancer agents
Zhang, L., Ren, W. T., Wang, X., Zhang, J., Liu, J., Zhao, L., & Zhang, X. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.12.021 · Cited by 25
Seo, J., Kim, D., Kim, S., Kim, H.-J., Ryu, H. G., Lee, J., Lee, K., & Kim, K. (2017) · Oncotarget · doi:10.18632/oncotarget.17003 · Cited by 27
Wang, J., Zhou, Y., Li, D., Sun, X., Deng, Y., & Zhao, Q. (2017) · FEBS Letters · doi:10.1002/1873-3468.12737 · Cited by 25
Peptide Hormone Regulation of DNA Damage Responses
Chesnokova, V., & Melmed, S. K. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa009 · Cited by 27
The complex architecture of p53 binding sites
Senitzki, A., Safieh, J., Sharma, V., Golovenko, D., Danin‐Poleg, Y., Inga, A., & Haran, T. E. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1283 · Cited by 25
Entosis is induced by ultraviolet radiation
Chen, R., Ram, A. R., Albeck, J. G., & Overholtzer, M. (2021) · iScience · doi:10.1016/j.isci.2021.102902 · Cited by 26
Zannoni, G. F., Bragantini, E., Castiglione, F., Fassan, M., Troncone, G., Inzani, F. S., Pesci, A., Santoro, A., & Fraggetta, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.805613 · Cited by 25
Panigrahi, A. K., & Pati, D. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.12.002 · Cited by 26
Phospho-ΔNp63α/SREBF1 protein interactions: Bridging cell metabolism and cisplatin chemoresistance
Huang, Y., Bell, L. N., Okamura, J., Kim, M. S., Mohney, R. P., Guerrero-Preston, R. E., & Ratovitski, E. A. (2012) · Cell Cycle · doi:10.4161/cc.22022 · Cited by 25
Waking up the sleepers: shared transcriptional pathways in axonal regeneration and neurogenesis
Quadrato, G., & Giovanni, S. D. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1099-x · Cited by 25
Longxi, P., Bu-wu, F., Yuan, W., & Gao, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026500 · Cited by 25
Ethayathulla, A. S., Nguyen, H. T., & Viadiu, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.408039 · Cited by 25
Hannemann, H., Rosenke, K., O’Dowd, J. M., & Fortunato, E. A. (2009) · Journal of Virology · doi:10.1128/jvi.02075-08 · Cited by 25
Ku80 Deletion Suppresses Spontaneous Tumors and Induces a p53-Mediated DNA Damage Response
Holcomb, V. B., Rodier, F., Choi, Y., Busuttil, R. A., Vogel, H. S., Vijg, J., Campisi, J., & Hasty, P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2085 · Cited by 25
Zhang, Y., Wang, S., Qian, W., Ji, D., Wang, Q., Zhang, Z., Wang, S., Ji, B., Fu, Z., & Sun, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6480 · Cited by 25
Age-related p53 SUMOylation accelerates senescence and tau pathology in Alzheimer’s disease
Wan, L., Yang, F., Yin, A., Luo, Y., Yi, L. I. U., Liu, F., Wang, J., Liu, R., & Wang, X. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01448-0 · Cited by 26
The Energy Costs of Insulators in Biochemical Networks
Barton, J. P., & Sontag, E. D. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.01.056 · Cited by 26
Self-citationMoxley, A. H., & Reisman, D. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3590 · Cited by 25
Si, W., Zhou, B., Xie, W. F., Li, H., Li, K., Li, S., Deng, W., Shi, P., Yuan, C., Ke, T., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.014 · Cited by 26
Jeffers, J. R., Pinto, E. M., Rehg, J. E., Clay, M. R., Wang, J., Neale, G. A. M., Heath, R. J., Lozano, G., Lalli, E., de Figueiredo, B. C., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1750 · Cited by 22
Redox Sensitive Cysteine Residues as Crucial Regulators of Wild-Type and Mutant p53 Isoforms
Butturini, E., Butera, G., Pacchiana, R., de Prati, A. C., Mariotto, S., & Donadelli, M. (2021) · Cells · doi:10.3390/cells10113149 · Cited by 25
Cruz-Garcia, L., Nasser, F., O’Brien, G., Grepl, J., Vinnikov, V. A., Starenkiy, V., Artiukh, S. V., Gramatiuk, S. M., & Badie, C. (2022) · Cancers · doi:10.3390/cancers14112649 · Cited by 27
Morawska–Kochman, M., Śmieszek, A., Marcinkowska, K. A., Marycz, K., Nelke, K., Zub, K., Zatoński, T., & Bochnia, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061400 · Cited by 28
Dynamic regulation of cancer stem cells and clinical challenges
Ni, C., & Huang, J. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0927-7 · Cited by 24
Tessler, L. A., & Mitra, R. D. (2011) · PROTEOMICS · doi:10.1002/pmic.201100361 · Cited by 24
Mende, M., Christophorou, N., & Streit, A. (2008) · Mechanisms of Development · doi:10.1016/j.mod.2008.08.005 · Cited by 24
Role of Rho-Kinase Gene Polymorphisms and Protein Expressions in Colorectal Cancer Development
Sarı, İ., Berberoğlu, B., Özkara, E., Öztuzcu, S., Camcı, C., & Demiryürek, A. T. (2013) · Pathobiology · doi:10.1159/000341395 · Cited by 24
Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling
Pishas, K. I., Neuhaus, S. J., Clayer, M., SCHREIBER, A. W., Lawrence, D., Perugini, M., Whitfield, R. J., Farshid, G., Manavis, J., Chryssidis, S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2424 · Cited by 24
Loss of p53-inducible long non-coding RNA LINC01021 increases chemosensitivity
Kaller, M., Götz, U., & Hermeking, H. (2017) · Oncotarget · doi:10.18632/oncotarget.22245 · Cited by 24
Survivin expression modulates the sensitivity of A549 lung cancer cells resistance to vincristine
Zhou, C., Zhu, Y., Lu, B., Zhao, W., & Zhao, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.9277 · Cited by 24
A Well-Controlled BioID Design for Endogenous Bait Proteins
Vandemoortele, G., Sutter, D. D., Moliere, A., Pauwels, J., Gevaert, K., & Eyckerman, S. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00367 · Cited by 22
p53, stem cell biology and childhood blastomas
Oh, L., Hafsi, H., Hainaut, P. L., & Ariffin, H. (2019) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000504 · Cited by 23
TP53 Polymorphisms in Sporadic North Indian Breast Cancer Patients
Sharma, S., Sambyal, V., Guleria, K., Manjari, M., Sudan, M., Uppal, M. S., Singh, N. R., Bansal, D., & Gupta, A. K. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.16.6871 · Cited by 23
Adefisan, A. O., Madu, J. C., Owumi, S. E., & Adaramoye, O. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220947387 · Cited by 23
p53 alters intracellular Ca2+ signaling through regulation of TRPM4
Kappel, S., Ross‐Kaschitza, D., Hauert, B., Rother, K., & Peinelt, C. (2022) · Cell Calcium · doi:10.1016/j.ceca.2022.102591 · Cited by 23
CDC20: a novel therapeutic target in cancer.
He, W., & Meng, J. (2023) · PubMed Central · Cited by 23
Cell Context Dependent p53 Genome-Wide Binding Patterns and Enrichment at Repeats
Botcheva, K., & McCorkle, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113492 · Cited by 23
Induction and activation of the p53 pathway: a role for the protein kinase CK2?
Meek, D. W., & Cox, M. L. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0966-3 · Cited by 26
Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis
Chander, H., Brien, C. D., Truesdell, P. F., Watt, K., Meens, J., Schick, C., Germain, D., & Craig, A. W. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0503-x · Cited by 23
Malčíková, J., Tichý, B., Damborský, J., Kabáthová, J., Trbušek, M., Mayer, J., & Pospı́šilová, Š. (2010) · Biological Chemistry · doi:10.1515/bc.2010.027 · Cited by 23
Heyne, K., Willnecker, V., Schneider, J., Conrad, M., Raulf, N., Schüle, R., & Roemer, K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq016 · Cited by 23
Neault, M., Couteau, F., Bonneau, É., Guire, V. D., & Mallette, F. A. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.001 · Cited by 23
Delay in development and behavioural abnormalities in the absence of p53 in zebrafish
Elabd, S., Jabeen, N. A., Gerber, V., Peravali, R., Bourdon, J., Kancherla, S., Vallone, D., & Blattner, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220069 · Cited by 20
Crosstalk Between Vitamin D and p53 Signaling in Cancer: An Update
Reichrath, J., Reichrath, S., VOGT, T. M., & Römer, K. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-46227-7_15 · Cited by 23
Afzal, S. M., Vafa, A., Rashid, S., Barnwal, P., Shahid, A., Shree, A., Islam, J., Ali, N., & Sultana, S. (2020) · Environmental Toxicology · doi:10.1002/tox.23068 · Cited by 23
Gristina, V., Mantia, M. L., Galvano, A., Cutaia, S., Barraco, N., Castiglia, M., Perez, A., Bono, M., Iacono, F., Greco, M., et al. (2021) · Journal of Molecular Pathology · doi:10.3390/jmp2020016 · Cited by 24
p53 mRNA Metabolism Links with the DNA Damage Response
Gnanasundram, S. V., Bonczek, O., Wang, L., Chen, S., & Fåhræus, R. (2021) · Genes · doi:10.3390/genes12091446 · Cited by 27
EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis
Liu, T., Wu, S., Huang, M.-H., Lo, F., Tsai, M., Tsai, C.-H. A., Hsu, S.-M., & Lin, C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-32 · Cited by 23
The can and can’t dos of p53 RNA
Candeias, M. M. (2011) · Biochimie · doi:10.1016/j.biochi.2011.06.010 · Cited by 23
Fuentes-Raspall, M. J., Caragol, I., Alonso, C., y Cajal, T. R., Fisas, D., Seoane, A., Carvajal, N., Bonache, S., Dı́ez, O., & Gutiérrez‐Enríquez, S. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1056-2 · Cited by 23
Li, Y., Chang, S., Niu, R., Liu, L., Crabtree-Ide, C. R., Zhao, B., Shi, J., Han, X., Li, J., Su, J., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-607 · Cited by 23
Peptide Activators of the p53 Tumor Suppressor
Zhan, C., & Lu, W. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795222577 · Cited by 23
Recent progress and open challenges in modeling p53 dynamics in single cells
Batchelor, E., & Loewer, A. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.04.007 · Cited by 23
p53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 29
Wilkie, M. D., Anaam, E. A., Lau, A., Rubbi, C. P., Jones, T. M., Boyd, M. T., & Vlatković, N. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.032 · Cited by 23
The p53 pathway in vasculature revisited: A therapeutic target for pathological vascular remodeling?
Cui, X., Pan, G., Chen, Y., Guo, X., Liu, T., Zhang, J., Yang, X., Cheng, M., Gao, H., & Jiang, F. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105683 · Cited by 21
Yang, V. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00008-6 · Cited by 24
Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic Program
Gencel‐Augusto, J., Su, X., Qi, Y., Whitley, E. M., Pant, V., Xiong, S., Shah, V. V., Lin, J., Perez, E., Fiorotto, M. L., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0872 · Cited by 22
Deleting Ku70 is milder than deleting Ku80 in p53-mutant mice and cells
Li, H.-Y., Choi, Y. J., Hanes, M. A., Marple, T. C., Vogel, H. S., & Hasty, P. (2009) · Oncogene · doi:10.1038/onc.2009.57 · Cited by 22
Cooperativity Dominates the Genomic Organization of p53-Response Elements: A Mechanistic View
Pan, Y., & Nussinov, R. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000448 · Cited by 22
Efficient motif search in ranked lists and applications to variable gap motifs
Leibovich, L., & Zohar Yakhini, B. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks206 · Cited by 22
Ostrakhovitch, E. A., Song, Y., & Cherian, M. G. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.01.008 · Cited by 23
p53 targets TSPAN8 to prevent invasion in melanoma cells
Agaësse, G., Barbollat‐Boutrand, L., Kharbili, M. E., Berthier‐Vergnes, O., & Masse, I. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.11 · Cited by 22
Beloglazkina, A. A., Karpov, N. A., Mefedova, S., Polyakov, V. S., Skvortsov, D. A., Kalinina, M., Тафеенко, В. А., Majouga, A. G., Zyk, N. V., & Beloglazkina, E. K. (2019) · Russian Chemical Bulletin · doi:10.1007/s11172-019-2511-6 · Cited by 22
Genipin increases oxaliplatin-induced cell death through autophagy in gastric cancer
Kim, B. R., Jeong, Y. A., Kim, D. Y., Kim, J. L., Jeong, S., Na, Y. J., Yun, H. K., Park, S. H., Jo, M. J., Ashktorab, H., et al. (2019) · Journal of Cancer · doi:10.7150/jca.34773 · Cited by 24
Targeted modulation of E3 ligases using engineered ubiquitin variants
LeBlanc, N., Mallette, E., & Zhang, W. (2020) · FEBS Journal · doi:10.1111/febs.15536 · Cited by 22
Modifying effect of MDM4 variants on risk of HPV16‐associated squamous cell carcinoma of oropharynx
Yu, H., Sturgis, E. M., Liu, Z., Wang, L., Wei, Q., & Li, G. (2011) · Cancer · doi:10.1002/cncr.26423 · Cited by 22
Soluble Guanylyl Cyclase α1 and p53 Cytoplasmic Sequestration and Down-Regulation in Prostate Cancer
Cai, C., Hsieh, C.-L., Gao, S., Kannan, A., Bhansali, M., Govardhan, K., Dutta, R. N., & Shemshedini, L. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0394 · Cited by 24
Metadata
- Authors
- Riley, T., Sontag, E., Chen, P., & Levine, A.
- Affiliations
- Institute for Advanced Study (US)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Riley, Todd
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2008-05
- Volume
- 9
- Issue
- 5
- Pages
- 402-412
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1964719993
- Cited by
- 1,921
- References
- 201
- Citations by year
- 2026: 36 · 2025: 45 · 2024: 56 · 2023: 73 · 2022: 85 · 2021: 97 · 2020: 79 · 2019: 92 · 2018: 110 · 2017: 134 · 2016: 131 · 2015: 115 · 2014: 154 · 2013: 143 · 2012: 153
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- p53, transcriptional regulation, p53 target genes, DNA damage response, DNA repair, cell cycle arrest, senescence, apoptosis, tumor suppression, transcription factor binding sites, stress signaling
- MeSH terms
- Base Sequence, Binding Sites, Cell Transformation, Neoplastic, DNA Damage, Gene Expression Regulation, Humans, Markov Chains, Molecular Sequence Data, Regulatory Sequences, Nucleic Acid, Transcription, Genetic, Signal Transduction, Genes, p53, Tumor Suppressor Protein p53, Response Elements, Regulatory Elements, Transcriptional
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review